摘要
目的探讨白介素-1受体拮抗剂基因(IL-1RA)及白介素-1β基因多态性与帕金森病(PD)的关系。方法本实验用PCR-片段长度多态性分析法检测了89例中国散发性帕金森病病人和67例正常对照的IL-1RA基因串联重复序列(VNTR)和IL-1β基因多态性。结果IL-1RAVNTR基因多态性在散发性PD组与正常对照组之间差异无统计学意义(P>0.05),IL-1RAVNTR基因多态性在帕金森病合并痴呆亚型(PDD组)和非痴呆亚型(PDND组)之间差异有统计学意义(P<0.05);IL-1β基因C-511T多态性在散发性PD组与正常对照组之间差异有统计学意义(P<0.05),但IL-1β基因C-511T多态性在PDD组和PDND组之间差异无统计学意义(P>0.05)。结论提示IL-1RA基因多态性可能与我国人散发性帕金森病的发病无关,而与帕金森病并发痴呆发病过程中有关;IL-1β可能是散发性帕金森病的易感基因之一。
Objective To explore the relationship between interleukin-1 receptor antagonist (IL-1RA) and interleukin-1β genetic polymorphism with sporadic Parkinson’s disease (PD).Methods IL-1RA and interleukin-1β genetic polymorphisms in 89 sporadic PD patients and 67 healthy controls were analyzed with the polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) technique.Results No statistically significant difference was found in IL-1RA genetic polymorphism between PD group and control group (P0.05),but there were statistically significant differences in IL-1RA genetic polymorphism between PD with dementia group (PDD) and PD without dementia group (PDND),(P0.05).There were statistically significant differences in interleukin-1β (C-511T) genetic polymorphism between PD and control groups (P0.05),but no statistically significant difference was found in interleukin-1β (C-511T) genetic polymorphism between PDD group and PDND group (P0.05).Conclusions The results suggest that IL-1RA genetic polymorphism may not be related to the pathogenesis of sporadic PD,but may be related to the pathogenesis of PDND.The IL-1β may be one of the susceptible genes for sporadic PD.
出处
《实用预防医学》
CAS
2010年第4期669-671,628,共4页
Practical Preventive Medicine
关键词
帕金森病
痴呆
白介素-1受体拮抗剂
多态性
Parkinson’s disease
Dementia
Interleukin-1 receptor antagonist
Polymorphism